Literature DB >> 1960733

Interaction of troponin I and troponin C. Use of the two-dimensional nuclear magnetic resonance transferred nuclear Overhauser effect to determine the structure of the inhibitory troponin I peptide when bound to skeletal troponin C.

A P Campbell1, B D Sykes.   

Abstract

We have used two-dimensional 1H nuclear magnetic resonance spectroscopy to determine the structure of the synthetic inhibitory peptide N alpha-acetyl TnI(104-115) amide bound to calcium-saturated skeletal troponin C (TnC). Conformational changes in the peptide induced by the formation of the troponin I (TnI) peptide-TnC complex were followed by the study of the transferred nuclear Overhauser effect, a technique that allows one to determine the structure of a ligand bound to a macromolecule. The structure of the bound TnI peptide reveals an amphiphilic alpha-helix, distorted around the two central proline residues. The central bend in the peptide functions to bring the residues on the hydrophobic face into closer proximity with each other, thereby forming a small hydrophobic pocket. The hydrophilic, basic residues extend off the opposite face of the peptide. Hydrophobic surfaces on TnC that become exposed upon binding of calcium are involved in the binding of the TnI peptide, but electrostatic interactions also contribute to the strength of the interaction. The role of amphiphilic helices in the targeting of calcium-binding proteins such as troponin C will be discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1960733     DOI: 10.1016/0022-2836(91)90219-v

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

Review 1.  Troponin I: inhibitor or facilitator.

Authors:  S V Perry
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  A model of troponin-I in complex with troponin-C using hybrid experimental data: the inhibitory region is a beta-hairpin.

Authors:  C S Tung; M E Wall; S C Gallagher; J Trewhella
Journal:  Protein Sci       Date:  2000-07       Impact factor: 6.725

3.  Interaction of human neutrophil flavocytochrome b with cytosolic proteins: transferred-NOESY NMR studies of a gp91phox C-terminal peptide bound to p47phox.

Authors:  E R Adams; E A Dratz; D Gizachew; F R Deleo; L Yu; B D Volpp; M Vlases; A J Jesaitis; M T Quinn
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 4.  Molecular mechanism of troponin-C function.

Authors:  Z Grabarek; T Tao; J Gergely
Journal:  J Muscle Res Cell Motil       Date:  1992-08       Impact factor: 2.698

Review 5.  Structural based insights into the role of troponin in cardiac muscle pathophysiology.

Authors:  Monica X Li; Xu Wang; Brian D Sykes
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

Review 6.  Interaction of cardiac troponin with cardiotonic drugs: a structural perspective.

Authors:  Monica X Li; Ian M Robertson; Brian D Sykes
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

7.  Crystal structure of troponin C in complex with troponin I fragment at 2.3-A resolution.

Authors:  D G Vassylyev; S Takeda; S Wakatsuki; K Maeda; Y Maéda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

8.  Binding of a high-energy substrate conformer in antibody catalysis.

Authors:  A P Campbell; T M Tarasow; W Massefski; P E Wright; D Hilvert
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Single histidine button in cardiac troponin I sustains heart performance in response to severe hypercapnic respiratory acidosis in vivo.

Authors:  Nathan J Palpant; Louis G D'Alecy; Joseph M Metzger
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

10.  An NMR and spin label study of the effects of binding calcium and troponin I inhibitory peptide to cardiac troponin C.

Authors:  J W Howarth; G A Krudy; X Lin; J A Putkey; P R Rosevear
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.